U.S. President-elect Donald Trump and Elon Musk watch the launch of the sixth test flight of the SpaceX Starship rocket in Brownsville, Texas, on Nov. 19, 2024.
Brandon Bell | Via Reuters
Tesla shares jumped to an all-time high on Wednesday, surpassing their prior record reached in 2021, sparked by a post-election rally and Wall Street’s increased enthusiasm for Elon Musk’s electric vehicle company.
The stock rose to an intraday high of $415, which is 50 cents above its previous peak, and was on pace to close ahead of its highest finish, which was $409.97 on Nov. 4, 2021.
Tesla’s market value has swelled by about 66% this year, with almost all of those gains coming since Donald Trump’s election victory early last month. The stock’s 38% rally in November marked its best monthly performance since January of 2023 and its 10th best on record.
Musk poured $277 million into a pro-Trump campaign effort, according to Federal Election Commission filings, and turned his support for the Republican nominee into another full-time job ahead of the election, funding a swing-state operation to register voters and using his social media platform X to constantly tout his preferred candidate, frequently with misinformation.
The world’s richest person, who’s seen his net worth swell to over $360 billion, is set to lead the Trump administration’s “Department of Government Efficiency,” alongside onetime Republican presidential candidate Vivek Ramaswamy.
His new role could give Musk power over federal agencies’ budgets, staffing and the ability to push for the elimination of inconvenient regulations. Musk said during a Tesla earnings call in October that he intended to use his sway with Trump to establish a “federal approval process for autonomous vehicles.” Currently, approvals happen at the state level.
“The stock is responding to the Trump bump,” Craig Irwin, an analyst at Roth MKM, told CNBC’s “Squawk on the Street” last week. Irwin had just increased his price target to $380 from $85, writing in a report that “Musk’s authentic support for Trump likely doubled Tesla’s pool of enthusiasts and lifted credibility for a demand inflection.”
On Wednesday, analysts at Goldman Sachs boosted their price target on Tesla, joining a parade of firms that have lifted their price expectation or their rating on the stock. The Goldman analysts wrote that “the market is taking a more forward-looking approach to Tesla, including with respect to its AI opportunity.”
Analysts at Morgan Stanley and Bank of America have also issued bullish reports of late.
Since Trump’s victory, Musk has been accompanying the president-elect in meetings with world leaders, and began advising him and members of Congress as to which federal agencies, regulations and budget items the billionaire would like to eliminate or greatly reduce.
Tesla’s surge to a record marks a dramatic turn from its performance to start the year. The company’s shares plunged 29% in the first three months of 2024, the worst quarter for the stock since the end of 2022 and the third worst since Tesla went public in 2010. At the time, investors were concerned about Tesla’s core business, which reported declining revenue in the first quarter in part due to increased competition from China.
In its third-quarter earnings report in October, Tesla reported a year-over-year revenue increase of 8%, which fell just shy of estimates. However, the company reported better-than-expected profit, and Musk said on the earnings call that his “best guess” is that “vehicle growth” will reach 20% to 30% next year, due to “lower cost vehicles” and the “advent of autonomy.” That forecast was ahead of analysts’ predictions.
The company rolled out the Meta AI app in April, putting it in direct competition with OpenAI’s ChatGPT. But the tool has recently garnered some negative publicity and sparked privacy concerns over some of the wacky — and personal — prompts being shared publicly from user accounts.
Besides the mud wrestlers and Trump eating poop, some of the examples CNBC found include a user prompting Meta’s AI tool to generate photos of the character Hello Kitty “tying a rope in a loop hanging from a barn rafter, standing on a stool.” Another user whose prompt was posted publicly asked Meta AI to send what appears to be a veterinarian bill to another person.
“sir, your home address is listed on there,” a user commented on the photo of the veterinarian bill.
Prompts put into the Meta AI tool appear to show up publicly on the app by default, but users can adjust settings on the app to protect their privacy.
Here’s how to do it:
To start, click on your profile photo on the top right corner of the screen and scroll down to data and privacy. Then head to the “suggesting your prompts on other apps” tab. This should include Facebook and Instagram. Once there, click the toggle feature for the apps that you want to keep your prompts from being shared on.
After, go back to the main data and privacy page and click “manage your information.” Select “make all your public prompts visible only to you” and click the “apply to all” function. You can also delete your prompt history there.
Meta has beefed up its recent bets on AI to improve its offerings to compete against megacap peers and leading AI contenders, such as Google and OpenAI. This week the company invested $14 billion in startup Scale AI and tapped its CEO Alexandr Wang to help lead the company’s AI strategy.
The company did not immediately respond to a request for comment.
A One Medical clinic location is pictured in Emeryville, California on February 16, 2024.
Loren Elliott | The Washington Post | Getty Images
For the better part of a decade, Amazon has been trying to carve it’s way into the U.S. health-care market, through billions of dollars worth of acquisitions, big-name hires and high-profile partnerships. It’s been a slog at times, and the company’s long-term strategy hasn’t always been clear.
Following a series of executive departures, Amazon is now restructuring its health business, telling CNBC that Amazon Health Services will be divided into six new units, with a goal of creating a simpler structure.
As part of the effort, the company has tapped a number of longtime Amazon leaders and elevated some One Medical executives to oversee the divisions. Neil Lindsay, senior vice president of Amazon Health Services told CNBC in an interview that the company has been working on the overhaul for the past several months.
“Our leadership team has been focused on simplifying our structure to move faster and continue to innovate effectively,” Lindsay said in a video chat. “One of the problems we’re trying to solve is the fragmented experience for patients and customers that’s common in healthcare.”
Amazon said it hasn’t conducted broad layoffs as part of the changes.
Read more CNBC tech news
The reorganization comes after Amazon lost several senior health leaders in recent months. Dr. Vin Gupta, who joined in 2020 and served as chief medical officer of Amazon Pharmacy, left in February, followed by Trent Green, whose last day as CEO of Amazon’s primary care chain One Medical was in April.
Aaron Martin, vice president of health care at Amazon, announced internally last month that he plans to leave his role. Dr. Sunita Mishra, Amazon’s chief medical officer, also departed in May.
Mishra and Martin’s departures have not been previously reported, and neither responded to requests for comment. Amazon doesn’t plan on naming a new CEO of One Medical following Green’s departure.
Martin, who lives in Nashville, Tennessee, said in a memo to staffers that he’ll remain at Amazon “for a while” to help with the transition.
“I then plan to take some time off this summer and hang out with my wife and my kids, finally get a cover band going in Nashville, and then possibly do something new,” Martin wrote in the memo, which was shared with CNBC.
Ambitious efforts
Amazon has for years been on a mission to crack the multitrillion-dollar U.S. health-care industry, which is notoriously complex and inefficient.
While it had long served providers and others in health care with its cloud-based technology, Amazon’s first big splash directly into the market came in 2018 with the the acquisition of online pharmacy PillPack for about $750 million. Two years later, it launched its own offering called Amazon Pharmacy.
The company then bought One Medical for $3.9 billion in 2023, among its largest acquisitions ever, giving Amazon access to a chain of brick-and-mortar primary care clinics and a robust membership base.
There have been some major setbacks. The company shuttered its telehealth service, Amazon Care, in 2022. That came a year after it disbanded Haven, the joint health-care venture between Amazon, Berkshire Hathaway and JPMorgan Chase. The announcement of Haven in 2018 sent shockwaves through the medical world, pushing down shares of health-care companies on fears about how the combined muscle of leaders in technology and finance could wring costs out of the system.
In the areas where Amazon continues to operate, competition is fierce and, in the case of primary care, margins are very slim.
PillPack founders TJ Parker and Elliot Cohen, who left Amazon in 2022, recently launched a new health-care marketplace called General Medicine that will compete with Amazon. Mishra confirmed to STAT News that she advised the nascent startup. Amazon declined to comment on whether Mishra’s involvement with General Medicine was related to her departure.
Lindsay characterized the recent departures as part of the natural evolution of Amazon’s health business. He added that there’s “no shortage of depth of talent” within his organization.
“We’re a fast-evolving organization because the opportunity is so big,” Lindsay said.
Under its new structure, Amazon Health Services will be focused around the six groups, or what the company calls “pillars.”
One Medical Clinical Care Delivery, led by Dr. Andrew Diamond
One Medical Clinical Operations and Performance, led by Suzanne Hansen
AHS Strategic Growth and Network Development, led by John Singerling
AHS Store, Tech and Marketing, led by Prakash Bulusu
AHS Compliance, led by Kim Otte
AHS Pharmacy Services, led by John Love
Amazon declined to share financial figures for its health business, but Lindsay said it is seeing “very strong growth” across the offerings.
One Medical went public in 2020, and it was still losing money when it was bought by Amazon. At the end of 2022 in its last quarter as a standalone entity, it reported a net loss of $101.1 million on revenue of $272.4 million.
Since joining Amazon, One Medical has been working to open new offices in states including New Jersey, New York and Ohio.
Amazon said in January of 2024 that its pharmacy business “doubled the number of customers” it served in the past year, though it didn’t share specific figures. The company is opening pharmacies in 20 new cities this year, and about 45% of U.S. customers will be eligible for same-day medication delivery.
“If we can make one thing a little bit easier for a lot of people, we’ll save them a lot of time, a lot of money, and some lives,” Lindsay said. “And if we stack these changes up over time, it’ll feel like a reinvention.”
The electric vertical takeoff and landing vehicle, or eVTOL, company said Thursday it plans to use the financing to support new infrastructure and the rollout of an artificial intelligence-based aviation software platform. The money will also support its Launch Edition program, including an official partnership to provide air taxi services during the 2028 Olympics in Los Angeles.
Archer said the funding round included the sale of 85 million shares at $10 apiece and gives the company a pro forma liquidity position of roughly $2 billion.
“We now have the strongest balance sheet in the sector and the resources we need to execute both here in the U.S. and abroad,” said founder and CEO Adam Goldstein in a release. “Archer’s future couldn’t be any brighter.”
The stock offering comes after President Donald Trump recently signed an executive order that created a pilot program to support developing and deploying more eVTOL vehicles in the U.S. Shares of both Archer and competitor Joby Aviation rallied this week on the heels of the news.
Demand for eVTOL companies has ballooned in recent years as developers tout the technology’s ability to reduce emissions and cut down traffic congestion. The technology faces numerous regulatory and safety hurdles in the process.
Archer has already partnered with United Airlines to roll out an airport air taxi service. Last month, competitor Joby Aviation said it received the first $250 million from a $500 million contract with carmaker Toyota to support certifying and producing eVTOLs.
Archer is slated to display its Midnight eVTOL aircraft at the Paris Air Show this month. The United Arab Emirates will be the company’s first launch market.